Skip to content
  • Argentina
  • Brazil
  • Canada
  • Chile
  • Colombia
  • Europe
  • France
  • Germany
  • India
  • Italy
  • Japan
  • Korea
  • Mexico
  • Perú
  • Russia
  • Spain
  • Taiwan
  • The Middle East
  • Turkey
  • United Kingdom
  • United States
  • Vietnam
  • USA
  • New Clinic Portal
    • 13055014948
  • Request Information
  • Part of brands: |
IGENOMIX – With science on your sideIGENOMIX – With science on your side
  • Part of brands: |
  • We guide you
    • Fertility
    • Blog
    • Patient Stories
  • Reproductive Health
    • Specialists
      • ERA
      • EndomeTRIO
      • EMMA
      • ALICE
      • PGT-A + ERA Synchrony
      • PGT-A
      • Family Balancing
      • EMBRACE
      • PGT-M
      • POC
      • SAT
    • Patients
      • ERA
      • EndomeTRIO
      • EMMA
      • ALICE
      • PGT-A + ERA Synchrony
      • PGT-A
      • Family Balancing
      • EMBRACE
      • PGT-M
      • POC
      • SAT
  • Kit Request
  • Genetic Counseling
  • Health Insurance
  • Education
    • Videos
    • Webinars
  • ACADEMY
  • About us
    • Igenomix Research
    • About Igenomix
  • Diagnostics

ERA® Endometrial Receptivity Analysis

OFFICIAL STATEMENT

Read official statement

Please visit the new corporate website of Vitrolife Group

Where you will find more information about investor relations, sustainability and career.

Visit Vitrolife Group Website

Endometrio Scientific Webinar

Optimal implantation solutions: Preparing a healthy and receptive endometrium.

 

WATCH WEBINAR

ERA®

HELPING OVERCOME RECURRENT IMPLANTATION FAILURE

Learn More

Endometrial micriota is essential to improve pregancy outcomes in RIF patients

Take a look at the latest independent publication showing how EMMA test helps RIF patients’ outcomes.

Learn More

Endometrial microbiota composition is associated with reproductive outcome in infertile patients

New study led by Dr. Inmaculada Moreno shows that endometrial microbiota composition before embryo transfer is an useful biomarker to predict reproductive outcome, offering an opportunity to further improve diagnosis and treatment strategies. 

 

Learn more! Watch our summary video



          Dr. Inma Moreno 
     Microbiome Jr Director

NEW INDEPENDENT ERA PUBLICATION

ERA-guided pETs significantly improves pregnancy rates compared to conventional FETs

 

Learn more!

ERA® Endometrial Receptivity Analysis

OFFICIAL STATEMENT

Read official statement

Endometrio Scientific Webinar

Optimal implantation solutions: Preparing a healthy and receptive endometrium.

 

WATCH WEBINAR

ERA is now covered by our fertility benefits partners

 

NEW INDEPENDENT ERA PUBLICATION

ERA-guided pETs significantly improves pregnancy rates compared to conventional FETs

 

Learn more!

500
SCIENTIFIC PUBLICATIONS

20
LABS WORLDWIDE

+600
professionals

+4
PATENTS

Genetic Solutions for Specialists

Igenomix offers pioneering tests to help reproductive health professionals diagnose and treat their patients.

Preconception

Detect genetic changes in the egg source or sperm source before conception so you can explore options to have a healthy baby

More information

Preimplantation

Help reduce the risk for implantation failure or miscarriage and improve the chances for a healthy pregnancy

More information

Prenatal

Understand whether a pregnancy is at an increased risk for a genetic syndrome

More information
See all services

Education

Fertility

Educational content for your particular reproductive journey

More information

Healthy Pregnancy

Avoid a miscarriage or an implantation failure

More information

Your Baby

Maximize your chances during an IVF treatment

More information
See all services

Research 

Igenomix Development

We actively works in research the most advanced techniques to reproductive genetics.

Igenomix Research

Providing solutions to professionals working in reproductive medicine

About Igenomix

Igenomix is a medical testing laboratory specializing in reproductive genetic services founded in 2011. 

We work to make a world in which infertility is no longer an impossible barrier. Together with clinics and fertility doctors worldwide, we investigate human reproduction to change the lives of couples who are trying to conceive. 

In 2021, Vitrolife acquired Igenomix. Together we create Vitrolife Group, a global leader in reproductive health. By combining Igenomix’s portfolio of reproductive genetic testing services with Vitrolife’s best-in-class IVF device portfolio, we support clinics and patients across the fertility journey. 

Learn more about Igenomix

Corporate News

More news

ERA Official Statement

We recognize the importance of addressing the ongoing concerns surrounding the paper titled “Personalized embryo transfer reduces success rates because endometrial receptivity analysis fails to accurately identify the window of implantation” by Kevin S. Richter and Martin L. Richter. We are fully committed to supporting you and standing by your side. Our main objective is to ensure that accurate information about our services reaches everyone. We are concerned about the potential impact misinformation can have on your patients. As experts in the field, we are firmly dedicated to sharing the correct data and providing clear guidance on the appropriate use of our services.

At Igenomix, we consistently leverage scientific advancements and stay at the forefront of research to enhance the accuracy and reliability of the ERA test. The credibility of the ERA test stems from its extensive scientific validation, with numerous publications confirming its effectiveness. Since 2011, over 200,000 women worldwide have undergone the ERA test provided by Igenomix.

The ERA test has yielded proven results, with more than 20 clinical studies conducted globally supporting its utilization. It was introduced as a solution for women experiencing repeated failed embryo transfers. When applied to this specific target population, the ERA test significantly increases the chances of achieving a successful pregnancy. Our goal at Igenomix is a healthy baby at home, and we are committed to making this a reality for our patients sooner rather than later.

You are welcome to connect with our scientific community for detailed explanations and support. Rest assured that we will stand by your side and assist you in helping your patients achieve a healthy pregnancy. Contact us by using the information listed below:

era@igenomix.com

WE GUIDE YOU

Fertility
COVID-19 basic Q&A

OUR SERVICES

For Health Specialists
For Patients

ABOUT US

About Igenomix
Contact
Press and news
Work with us
Quality

FOLLOW IGENOMIX

Blog: Road to fertility

 

*CAP accreditation applies to the LA lab.

 

  +1 (305) 501-4948 
  Email us
  • Argentina
  • Brazil
  • Canada
  • Chile
  • Colombia
  • Europe
  • France
  • Germany
  • India
  • Italy
  • Japan
  • Korea
  • Mexico
  • Perú
  • Russia
  • Spain
  • Taiwan
  • The Middle East
  • Turkey
  • United Kingdom
  • United States
  • Vietnam
Language

[2019] © Igenomix Privacy policy & cookies policy Quality policy Terms & conditions User Feedback

Open this in UX Builder to add and edit content

Request Information

Copyright 2023 © UX Themes
  • We guide you
    • Fertility
    • Blog
    • Patient Stories
  • Reproductive Health
    • Specialists
      • ERA
      • EndomeTRIO
      • EMMA
      • ALICE
      • PGT-A + ERA Synchrony
      • PGT-A
      • Family Balancing
      • EMBRACE
      • PGT-M
      • POC
      • SAT
    • Patients
      • ERA
      • EndomeTRIO
      • EMMA
      • ALICE
      • PGT-A + ERA Synchrony
      • PGT-A
      • Family Balancing
      • EMBRACE
      • PGT-M
      • POC
      • SAT
  • Kit Request
  • Genetic Counseling
  • Health Insurance
  • Education
    • Videos
    • Webinars
  • ACADEMY
  • About us
    • Igenomix Research
    • About Igenomix
  • Diagnostics
  • USA
  • New Clinic Portal
Free Call Contact us